COX-2 targeting in cancer: a new beginning? (English)
- New search for: Milella, M.
- New search for: Metro, G.
- New search for: Gelibter, A.
- New search for: Pino, S. M.
- New search for: Cognetti, F.
- New search for: Fabi, A.
- New search for: Milella, M.
- New search for: Metro, G.
- New search for: Gelibter, A.
- New search for: Pino, S. M.
- New search for: Cognetti, F.
- New search for: Fabi, A.
In:
ANNALS OF ONCOLOGY
;
19
, 6
;
1209-1210
;
2008
-
ISSN:
- Article (Journal) / Print
-
Title:COX-2 targeting in cancer: a new beginning?
-
Contributors:Milella, M. ( author ) / Metro, G. ( author ) / Gelibter, A. ( author ) / Pino, S. M. ( author ) / Cognetti, F. ( author ) / Fabi, A. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 19, 6 ; 1209-1210
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2008-01-01
-
Size:2 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 19, Issue 6
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1031
-
In this issue| 2008
- 1033
-
The perspective and role of the medical oncologist in cancer prevention: A position paper by the European Society for Medical Oncology| 2008
- 1036
-
EGFR regulation by microRNA in lung cancer: a rose by any other name is an increasingly complicated roseHayes, D. N. / McLeod, H. L. et al. | 2008
- 1039
-
Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trialsYang, S. H. / Yang, K. H. / Li, Y. P. / Zhang, Y. C. / He, X. D. / Song, A. L. / Tian, J. H. / Jiang, L. / Bai, Z. G. / He, L. F. et al. | 2008
- 1045
-
The role of UFT in advanced gastric cancerAykan, N. F. / Idelevich, E. et al. | 2008
- 1053
-
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell linesWeiss, G. J. / Bemis, L. T. / Nakajima, E. / Sugita, M. / Birks, D. K. / Robinson, W. A. / Varella-Garcia, M. / Bunn, P. A. / Haney, J. / Helfrich, B. A. et al. | 2008
- 1060
-
A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytesYada, A. / Yazawa, M. / Ishida, S. / Yoshida, H. / Ichikawa, K. / Kurakata, S. / Fujiwara, K. et al. | 2008
- 1068
-
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancerBurstein, H. J. / Storniolo, A. M. / Franco, S. / Forster, J. / Stein, S. / Rubin, S. / Salazar, V. M. / Blackwell, K. L. et al. | 2008
- 1075
-
ADAM-17 predicts adverse outcome in patients with breast cancerMcGowan, P. M. / McKiernan, E. / Bolster, F. / Ryan, B. M. / Hill, A. D. / McDermott, E. W. / Evoy, D. / OHiggins, N. / Crown, J. / Duffy, M. J. et al. | 2008
- 1082
-
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-upZander, A. R. / Schmoor, C. / Kroger, N. / Kruger, W. / Mobus, V. / Frickhofen, N. / Metzner, B. / Berdel, W. E. / Koenigsmann, M. / Thiel, E. et al. | 2008
- 1090
-
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialUntch, M. / Gelber, R. D. / Jackisch, C. / Procter, M. / Baselga, J. / Bell, R. / Cameron, D. / Bari, M. / Smith, I. / Leyland-Jones, B. et al. | 2008
- 1097
-
Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cellsVazquez-Martin, A. / Oliveras-Ferraros, C. / Colomer, R. / Brunet, J. / Menendez, J. A. et al. | 2008
- 1110
-
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric studyBelkacemi, Y. / Gligorov, J. / Ozsahin, M. / Marsiglia, H. / De Lafontan, B. / Laharie-Mineur, H. / Aimard, L. / Antoine, E. C. / Cutuli, B. / Namer, M. et al. | 2008
- 1117
-
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trialsCollette, S. / Bonnetain, F. / Paoletti, X. / Doffoel, M. / Bouche, O. / Raoul, J. L. / Rougier, P. / Masskouri, F. / Bedenne, L. / Barbare, J. C. et al. | 2008
- 1127
-
Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patientsvan Iersel, L. B. / Gelderblom, H. / Vahrmeijer, A. L. / van Persijn van Meerten, E. L. / Tijl, F. G. / Putter, H. / Hartgrink, H. H. / Kuppen, P. J. / Nortier, J. W. / Tollenaar, R. A. et al. | 2008
- 1135
-
Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancerJeong, J. / Jeung, H. C. / Rha, S. Y. / Im, C. K. / Shin, S. J. / Ahn, J. B. / Noh, S. H. / Roh, J. K. / Chung, H. C. et al. | 2008
- 1141
-
Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracilPfeiffer, P. / Nielsen, D. / Bjerregaard, J. / Qvortrup, C. / Yilmaz, M. / Jensen, B. et al. | 2008
- 1146
-
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastasesCheon, S. H. / Rha, S. Y. / Jeung, H. C. / Im, C. K. / Kim, S. H. / Kim, H. R. / Ahn, J. B. / Roh, J. K. / Noh, S. H. / Chung, H. C. et al. | 2008
- 1154
-
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracilQvortrup, C. / Yilmaz, M. / Ogreid, D. / Berglund, A. / Balteskard, L. / Ploen, J. / Fokstuen, T. / Starkhammar, H. / Sorbye, H. / Tveit, K. et al. | 2008
- 1160
-
Bortezomib, doxorubicin and dexamethasone in advanced multiple myelomaPalumbo, A. / Gay, F. / Bringhen, S. / Falcone, A. / Pescosta, N. / Callea, V. / Caravita, T. / Morabito, F. / Magarotto, V. / Ruggeri, M. et al. | 2008
- 1166
-
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkins lymphoma in patients >65 years of ageHosing, C. / Saliba, R. M. / Okoroji, G. J. / Popat, U. / Couriel, D. / Ali, T. / De Padua Silva, L. / Kebriaei, P. / Alousi, A. / De Lima, M. et al. | 2008
- 1172
-
Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC)Abdalla, A. O. / Kokhaei, P. / Hansson, L. / Mellstedt, H. / Osterborg, A. et al. | 2008
- 1180
-
The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979-2003)Chen, M. C. / Feng, I. J. / Lu, C. H. / Chen, C. C. / Lin, J. T. / Huang, S. H. / Lee, K. D. et al. | 2008
- 1187
-
Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populationsHery, C. / Ferlay, J. / Boniol, M. / Autier, P. et al. | 2008
- 1195
-
Adjuvant low-dose interferon a2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasisGarbe, C. / Radny, P. / Linse, R. / Dummer, R. / Gutzmer, R. / Ulrich, J. / Stadler, R. / Weichenthal, M. / Eigentler, T. / Ellwanger, U. et al. | 2008
- 1203
-
How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?Harputluoglu, H. / Altundag, K. et al. | 2008
- 1203
-
The potential role of positron emission tomography in the detection of occult cancer in 25 patients with venous thromboembolismBeckers, M. M. / Verzijlbergen, J. F. / van Buul, M. M. / Prins, M. H. / Biesma, D. H. et al. | 2008
- 1204
-
Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpuraSpoormans, I. / Altintas, S. / Van den Brande, J. / Luijks, A. / Vermorken, J. B. et al. | 2008
- 1207
-
ISO 9001:2000 applied to a research oncology laboratory: which problems? The experience of National Cancer Institute-BariLacalamita, R. / Schirone, M. / Paradiso, A. et al. | 2008
- 1208
-
A rationale for starting breast cancer screening under age 50van Schoor, G. / Broeders, M. J. / Paap, E. / Otten, J. D. / den Heeten, G. J. / Verbeek, A. L. et al. | 2008
- 1209
-
COX-2 targeting in cancer: a new beginning?Milella, M. / Metro, G. / Gelibter, A. / Pino, S. M. / Cognetti, F. / Fabi, A. et al. | 2008